• Citer

A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.

par Trakatelli, Myrto Georgia ;Toungouz Nevessignsky, Michel ;Blocklet, Didier ;Dodoo, Ygierne;Gordower, Laurence ;Laporte, Marianne;Vereecken, Pierre ;Sales, Francois;Mortier, Laurent;Mazouz, Naima ;Lambermont, Micheline ;Goldman, Serge ;Coulie, Pierre G;Goldman, Michel ;Velu, Thierry
Référence Cancer immunology and immunotherapy, 55, 4, page (469-474)
Publication Publié, 2006-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
Auteur:	Trakatelli, Myrto Georgia; Toungouz Nevessignsky, Michel; Blocklet, Didier; Dodoo, Ygierne; Gordower, Laurence; Laporte, Marianne; Vereecken, Pierre; Sales, Francois; Mortier, Laurent; Mazouz, Naima; Lambermont, Micheline; Goldman, Serge; Coulie, Pierre G; Goldman, Michel; Velu, Thierry
Informations sur la publication:	Cancer immunology and immunotherapy, 55, 4, page (469-474)
Statut de publication:	Publié, 2006-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antigens, Neoplasm -- immunology
	CD8-Positive T-Lymphocytes
	Cancer Vaccines -- immunology
	Cell Culture Techniques
	Cell Movement
	Dendritic Cells -- immunology
	Female
	Humans
	Immunotherapy -- methods
	Interferon-beta -- immunology
	Interleukin-3 -- immunology
	Lymph Nodes -- immunology
	Male
	Melanoma -- immunology
	Melanoma -- pathology
	Melanoma -- therapy
	Middle Aged
	Skin Neoplasms -- immunology
	Skin Neoplasms -- pathology
	Skin Neoplasms -- therapy
Note générale:	Clinical Trial
	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0340-7004
	info:doi/10.1007/s00262-005-0056-z
	info:scp/30444445122
	info:pmid/16133111